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1. Abstract 
This study examines platelet adhesion on surfaces that combine coatings to limit protein 
adsorption along with "anti-platelet" nitric oxide (NO) release. Uncoated and poly-2-
methoxyethylacrylate (PMEA) coated, gas permeable polypropylene (PP) membranes were 
placed in a bioreactor to separate plasma and gas flows. Nitrogen with 100/500/1000 ppm of NO 
was supplied to the gas side as a proof of concept. On the plasma side, platelet rich plasma 
(PRP, 1x108 cell/mL) was recirculated at low (60)/high (300) flows (ml/min). After 8 hours, 
adsorbed platelets on PP was quantified via a lactate dehydrogenase assay. Compared to plain 
PP, the PMEA coating alone reduced adsorption by 17.4±9.2% and 29.6±16.6% at low and high 
flow (p<0.05), respectively. NO was more effective at low plasma flow. At 100 and 500 ppm of 
NO, adsorption fell by 37.9±6.1% and 100±4.7%, (p<0.001), on plain PP. At high flow with 100, 
500, and 1000 ppm of NO, adsorption reduced by 17.9±17.8%, 46.4±23.2%, and 100±4.8%, 
(p<0.001), respectively. On PMEA-coated PP with only 100 ppm, adsorption fell by 69.7±6.8 and 
65.6%±16.9%, (p< 0.001), at low and high flows respectively. Therefore, the combination of an 
anti-adsorptive coating with NO has great potential to reduce platelet adhesion and coagulation at 
biomaterial surfaces. 
 
2. Introduction  
Various artificial organs, catheters, stents, and other medical devices operate under long-term 
blood contact. Protein adsorption and platelet activation on the surfaces of these devices lead to 
clot formation. This, in turn, causes device failure and thromboembolic complications. The most 
common solution to this problem is systemic anticoagulation, but this leads to bleeding 
complications that can also contribute to patient morbidity and mortality. [1-3] Anticoagulation that 
is limited only upon device surfaces could remedy these shortcomings.  
 Two methods of surface focused anticoagulation have demonstrated some promise in 
reducing coagulation: surface coatings designed to limit nonspecific protein adsorption and anti-
platelet surface NO release. Surface coatings only reduce coagulation in the device and thus 
have no systemic anticoagulant effect.  Various commercial anti-thrombogenic coatings have 
shown better preservation of platelet counts than the uncoated control surface [4,5] during short-
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term applications. However, these surface coatings have not yet proven sufficient to allow the 
elimination of systemic anticoagulation or long-term use of high surface area artificial organs 
without significant decrease in systemic platelet concentration. [6, 7]  
 Nitric oxide is released from biomaterials into flowing blood, [8-12] but has a short half-life 
of 2-5 seconds [8] in blood prior to being scavenged. Thus, its systemic effects are minor, and it 
has been examined as a means to focus anticoagulation at biomaterials’ surfaces rather than 
systemically. Several means of supplying surface NO flux have been tested.  They include NO 
release from a stored pool in the biomaterial, NO generation from endogenous sources in blood, 
and NO delivery via the gas flow in artificial lungs. [9 -12] Early studies examining the latter 
approach were largely unsuccessful. These studies did not quantify surface NO flux, and it was 
likely insufficient. [13] More recent studies with proven, endothelial levels of NO flux (> 2x10-10 
mol/min/cm2) have been successful, reducing platelet adhesion in tubing and catheters by 
approximately 40%, [9, 10] and markedly reducing coagulation and increasing longevity in artificial 
lungs. [12]  Although positive, these studies were all for a period of 4 hours. Longer-term 
effectiveness in these settings is unknown. Additionally, use of NO in high surface area artificial 
organs could lead to excessive generation of methemoglobin in the blood, limiting the possible 
flux rates, and anticoagulation.   
In this study, we hypothesize that the combination of anti-adsorptive coatings and surface 
NO flux will lead to more effective surface-focused anticoagulation. Anti-adsorptive coatings 
would limit protein adsorption, thereby reducing platelet activation induced via surface adhesion 
or surface-generation of agonists. In theory, a lower level of NO could then be used to 
anesthetize the limited number of platelets that adhere to the surface or contact the lower levels 
of soluble agonists. In this way, the surface would operate more like the endothelium, which uses 
several simultaneous methods to control coagulation. [14 - 16]  
To examine this hypothesis, bioreactors were constructed with gas permeable 
polypropylene membranes. The bioreactors were then used to determine the relationship 
between sweep gas concentration and NO flux. Platelet rich plasma was recirculated over 
polypropylene membranes that were either uncoated or coated with PMEA. Various levels of NO 
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(300 ml/min) and at low flow (60 mL/min), while N2 with 100 ppm and 500ppm of NO flowed over 
the opposite surface. PBS samples were taken before initiating flow and at 3min, 5min, 10min, 
20min and 30min of recirculation. PBS NO concentrations were immediately measured with a 
Sievers Nitric Oxide Analyzer 280i (GE Instruments, Boulder, CO) using standard wet-phase 
measurement methods. The NO flux at each sampling time, JNO t=x (mol/min/cm
2), was first 
calculated as the change in NO concentration between current and previous samples divided by 
time elapsed between sampling times and membrane surface area. JNO at each time point was 
then used to calculate NO mass transfer coefficient, Kc (cm/min), for each time point. Kc was 
calculated as Kc = JNO/([NO]max - [NO]measured), where [NO]max (mol/ml) is the maximum achievable 
[NO] in PBS at the temperature and pressure from the NO gas concentration. We used 1.94 x 
10−3 mol L−1 atm−1 as a reference value for the solubility of NO in PBS. [17] The Kc values at all 
sampling times were plotted and a linear regression line was used to estimate NO’s mass transfer 
coefficient at the onset of NO gas flow Kc(t=0). Having determined Kc(t=0) and [NO]max, the JNO 
through the tested PP membranes was calculated as JNO = Kc(t=0) x [NO]max.  
 
3.3 Platelet Adhesion Studies: Effect of NO Flux and Surface Coating  
All platelet adhesion studies utilized freshly drawn sheep plasma. The animal handling and 
surgical procedures were approved by the University Committee on the Use and Care of Animals 
in accordance with University of Michigan and federal regulations. Sheep whole blood was gravity 
drawn into a blood transfer blood bag (1:10 acid citrate dextrose 4% (ACD) anticoagulant, Sigma 
Aldrich St Louis MO). Whole blood from the bag was then carefully transferred to 50 mL 
centrifuge tubes and centrifuged at 730 rpm for 20 min to generate PRP. Platelet rich plasma was 
then recovered, and the remaining blood was centrifuged at 2750 rpm for 15 min to obtain platelet 
poor plasma (PPP). A Beckman-Coulter particle counter (Z1 Coulter Particle Counter, 
Indianapolis IN) was then used to determine platelet counts of the PRP and PPP. The PRP and 
PPP were then mixed to obtain 1x108 cells/mL.  
 Twenty-five milimeters of this mixture was injected into each of the three bioreactors. 
Each bioreactor was fitted with a 3’’ x 0.5’’ gas permeable PP membrane with an average pore 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
?????????????????????????????????? ????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????? ?????????????
?????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????
?
??????????????????????????????????????????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????
?????????????? ?? ????????????????????? ?? ?????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????
? ?????????????????????????????????????????????????????????????????????????? ????????
?? ?????????????????????????????????? ?????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????? ???????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????? ????????
??
??
??
??
??
??
??
??
??
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
???
was then sectioned lengthwise into two halves. One half was assayed for LDH, and the other half 
was fixed for SEM analysis (see sections 3.6 and 3.7). Experimental runs with three circuits were 
repeated until five experiments were performed for each coating, NO concentration, and PRP 
flow rate combination. 
 
3.4 Lactate Dehydrogenase (LDH) Assay  
A lactate dehydrogenase (LDH) assay kit (Cayman Chemicals Ann Arbor, 10008882) was used to 
quantify platelets adhered on the surface of each membrane after 8 hours of PRP exposure in the 
bioreactor. Each membrane section was incubated at 37ºC in two mL of lysing reagent (1% 
Triton-X100, 0.75% Bovine Albumin Serum in phosphate buffered saline) for 1hr, with occasional 
agitation. The suspension was then assayed for LDH according to the kit manufacturer's protocol.  
To convert LDH concentration to the number of adhered cells, a calibration curve was first 
constructed. PRP (7x108 platelets/mL) was serially diluted with PPP to achieve platelet 
concentrations of 4.7x108, 2.4x108, 1.2x108, 6.0x107, 3.0x107, 1.5x107, and 7.5x106 cell/ml and 
were assayed for LDH. A linear curve fit was then used to determine the relationship between 
absorbance from LDH and number of cells. This curve was found to be LDHabsorbance = 0.12 x 
platelets (x106 cells/mL) + 0.01, (R2 = 0.99). 
 
3.5 SEM Analysis 
One half of each tested membrane was fixed with 2% gluteraldehyde (Sigma Aldrich, ST Louis 
MO) overnight and then dehydrated in a series of ethanol solutions and completely dried. The 
mid-section of the membrane was cut, sputter-coated with gold, and imaged by a Hitachi S-
3200N scanning electron microscope (15 kV). 
 
3.6 Data and Statistical Analysis 
Raw LDH data obtained from coated and uncoated samples were adjusted to remove 
background LDH levels. To do so, a control study was run using PBS only in the circuit and 
assaying these membranes for LDH in the described manner (n=4). The average background 
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LDH data was then subtracted from the LDH concentrations measured in all studies. Any results 
giving a number below this value were given an adjusted LDH value of zero. Adjusted LDH data 
of test samples was then normalized by expressing the data as a percentage of LDH data 
obtained from uncoated control PP. Lastly, the calibration curve between LDH and platelet count 
was used to determine the number of adhered platelets, which was then divided by the surface 
area of test sample to give platelets/cm2. Statistics was performed on normalized LDH data using 
the Origin statistical package (OriginLab, Northampton MA). Specifically, one-way analysis of 
variance (ANOVA) with a Tukey’s post hoc analysis was used to compare normalized data. 
Statistical significance was set to p<0.05. Numerical values are presented as mean +/- standard 
deviation.   
 
4. Results  
Nitric oxide concentration in water over time exhibited the characteristic curve shown in Figure 3. 
The gas’ concentration in water steadily increased during recirculation of PBS and flow of NO 
gas. After reaching the solubility limit, NO concentration remained fairly constant at the 
temperature and pressure for each test condition. At low PBS flow, JNO was calculated to be (2.40 
± 1.63) x 10-10 mol/min/cm2 from 100 ppm sweep gas NO and (11.17 ± 2.98) x 10-10 mol/min/cm2 
from 500 ppm sweep gas NO. At high flow, the same JNO were 1.70 ± 0.56 x 10
-10 mol/min/cm2 
and 21.13 ± 1.97 x 10-10 mol/min/cm2. See Figure 4. These values are similar to NO flux levels 
reported to significantly inhibit clot formation. [9 -11]   
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This suggests two things.  First, NO should be more effective in stagnant regions where 
clots typical form in medical devices. Local Peclet numbers will be small, nitric oxide will 
accumulate, and this should have a greater effect than local procoagulant accumulation. Second, 
NO will be less effective in whole blood. At the same Reynolds number, the Peclet number will be 
larger because of 1) higher blood viscosity (≈ 4x water) and 2) a smaller effective NO diffusivity 
due to NO scavenging by red blood cells (RBCs). [20]  The extent of this effect, however, will vary 
from application to application. In all situations, there will be a cell-free, exclusionary layer near 
the surface that contains only platelet rich plasma, which may moderate the effect of RBCs. The 
thickness of this zone in laminar flows is on the order of the RBC diameter, 8 μm, but will varies 
with local fluid mechanics. [21-23] Further studies are thus necessary to examine the effect of RBCs 
on NO inhibition of platelets in various whole blood flow conditions. 
Several other limitations should be considered in the interpretation of these results. First, 
the test system was a closed in-vitro circuit. Thus, both NO concentration and surface–generated 
procoagulant molecules accumulate over time. If used in-vivo with whole blood, such 
accumulation would not occur due to RBC binding and by clearance of procoagulant molecules.  
Second, NO delivery was provided in this study via diffusion from an N2 and NO mixture. 
This served as a relatively simple means to approximate NO release from NO donors in polymers 
[24] and estimate NO fluxes. However, as mentioned previously, NO flux rates and local 
concentrations will be different in blood due to the presence of NO scavengers. Furthermore, the 
effect of NO will vary slightly if NO is catalytically generated from donors in blood [25], or if NO is 
mixed with O2 immediately prior to delivery to artificial lungs. In the former case, the effect of local 
flow rate will be different, as increased flow rate will also increase transport of NO donors to the 
polymer surface. In the latter, NO will be transported in part as nitrite or nitrate, which could 
reduce platelet inhibition.  
On the positive side, this technique could be attempted with other polymer coatings. 
PMEA has been determined to be the most effective anti-protein coating of the acrylate polymers, 
but it’s also one of many low-fouling polymers available [26]. Another, promising type of non-
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
fouling coating are those composed of zwitterionic polymers. This class of polymers 
demonstrates far lower protein adsorption (<0.3 pg/cm2) after incubation with 100% plasma and 
whole blood under static conditions [27 - 36]. Protein adsorption on PMEA coatings, however, has 
been reported as 300 pg/cm2 [37]. Thus, zwitterionic coatings may prove even more effective when 
combined with NO, allowing for even greater platelet inhibition at low NO concentrations. This, in 
turn, would help avoid the metHb generation by nitric oxide.  
 
6. Conclusion 
Alone, PMEA, protein-adsorption resistant coatings and surface NO flux both reduce platelet 
adhesion on polypropylene membranes. When PMEA coatings and NO release were combined, 
platelet adhesion was significantly lower. Furthermore, the reduction in platelet adhesion was 
greater than what would be predicted by the addition of reductions in adhesion caused by PMEA 
and NO alone. Thus, combining non-fouling surface coatings with surface NO release acts 
synergistically. Future work should test new, ultra-low fouling coatings with different means of 
surface NO delivery. 
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Figure Captions 
Figure 1. Bioreactor flow cell; exploded view of flow cell showing platelet rich plasma (PRP) flow 
chamber, test membrane, and sweep gas flow chamber (A) and assembled bioreactor showing 
PRP and NO gas counter-current flow (B).   
Figure 2. Surface chemical composition and chemical spectra of plain polypropylene (A), and 
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PMEA-coated polypropylene (B).    
Figure 3. Nitric oxide (NO) concentration in water during recirculation of water at 120 ml/min and 
500 ppm NO gas flow at 300 ml/min. 
Figure 4. NO flux, JNO, across gas permeable PP membrane after 10 minutes of low (60ml/min) 
and high (300ml/min) PBS flows. 
Figure 5. Platelet adsorption at high flow, 300 ml/min (A) and low flow, 60 ml/min (B) on PP and 
PMEA-coated PP membranes. Other panels show platelet adsorption at high and low flows on 
PP (C) and on PMEA-coated PP (D) membranes. * Indicates (p<0.05) significance. 
Figure 6. Scanning electron micrographs of fouling levels on PP and PMEA-coated PP 
membranes with 0 -500 ppm NO gas flows and 60 ml/min blood plasma flow. 
Figure 7. Scanning electron micrographs of fouling levels on PP and PMEA-coated PP 
membranes with 0 -1000 ppm NO gas flows and 300 ml/min blood plasma flow. 
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